Thierry Duvauchelle - Concepedia

Author

Thierry Duvauchelle

Bioprojet (France)ORCID

Also Known As

T Duvauchelle, T. Duvauchelle, THIERRY DUVAUCHELLE, Thierry Duvauchelle

Publications

521

Citations

H-Index

Concepts

All Affiliations

Bioprojet (France)ASTER Centre for Addiction and Mental Health Chiesi (France)University of Toronto

About

Thierry Duvauchelle is an author at Bioprojet (France) specializing in pharmacology, medicine, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	244
2	Pharmacology	6	6	244
3	Clinical Pharmacology	3	3	59
4	Neuroscience	1	1	19
5	Clinical Chemistry	1	1	17

Thierry Duvauchelle

Publications

484

Citations

H-Index

Page 1

	Year	Citations
Single-Dose Clinical Pharmacokinetic Studies of Gefitinib Helen Swaisland, Robert P. Smith, Alison Laight, Clinical Pharmacokinetics MedicinePharmacotherapyPharmacologyPhysiologically-based Pharmacokinetic ModelingPharmacokinetics	2005	141
First Pharmacokinetic—Pharmacodynamic Study in Humans with a Selective 5‐Hydroxytryptamine<sub>4</sub> Receptor Agonist Silke Appel, Anette Kumle, Martine Hubert, The Journal of Clinical Pharmacology	1997	67
Bioavailability and Cardiovascular Effects of Adrenaline Administered by Anapen Autoinjector in Healthy Volunteers Thierry Duvauchelle, Philippe Robert, Yves Donazzolo, The Journal of Allergy and Clinical Immunology In Practice	2017	51
Pharmacokinetic Drug Interactions with Vandetanib during Coadministration with Rifampicin or Itraconazole Paul Martin, Stuart Oliver, Jane Robertson, Drugs in R&D	2011	49
Absence of Interaction of Fondaparinux Sodium with Aspirin and Piroxicam in Healthy Male Volunteers Céline Ollier, Richard A. Faaij, Alix Santoni, Clinical Pharmacokinetics Fondaparinux SodiumHypertensionCardiovascular DiseaseHealthy Male VolunteersPharmacology	2002	31
Determination of the Optimal Single Dose Treatment for Acoziborole, a Novel Drug for the Treatment of Human African Trypanosomiasis: First-in-Human Study Antoine Tarral, Lionel Hovsepian, Thierry Duvauchelle, Clinical Pharmacokinetics	2023	28
Pharmacokinetics of pitolisant in children and adolescents with narcolepsy Michel Lecendreux, Giuseppe Plazzi, Patricia Franco, Sleep Medicine PharmacologyPharmacotherapyPharmacokineticsMedicine	2019	25
Exploring occupancy of the histamine H<sub>3</sub> receptor by pitolisant in humans using PET Pablo Rusjan, Pamela Sabioni, Patricia Di Ciano, British Journal of Pharmacology	2020	21
Occupancy of dopamine D2 and D3 receptors by a novel D3 partial agonist BP1.4979: a [11C]-(+)-PHNO PET study in humans Patricia Di Ciano, Esmaeil Mansouri, Junchao Tong, Neuropsychopharmacology Molecular PharmacologyD3 ReceptorsFunctional SelectivityMedicinePhysiology	2018	19
Establishing assay sensitivity in QT studies: experience with the use of moxifloxacin in an early phase clinical pharmacology study and comparison with its effect in a thorough QT study Rashmi R. Shah, Pierre Maison‐Blanche, Thierry Duvauchelle, European Journal of Clinical Pharmacology Assay SensitivityMoxibustionPreclinical Drug EvaluationPharmacologyQt Studies	2015	17

Page 1